Alexander M. Herrmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander M. Herrmann has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Stefan Bittner
Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (Rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
6 shared publications - Sven Guenther Meuth
Department of Neurology, University Hospital Münster
5 shared publications - Nico Melzer
Department of Neurology, Medical Faculty and University Hospital, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
4 shared publications - Christoph Kleinschnitz
Department of Neurology, University Hospital Essen, Essen, Germany
3 shared publications - Heinz Wiendl
From the Department of Neurology and Neuroscience, Medical Center and Faculty of Medicine, University of Freiburg, Germany
3 shared publications - Thomas Budde
Institute of Physiology I, University of Münster
3 shared publications
Latest Publications
- 22 February 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (9)
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA A receptor encephalitis
Significance: Antibodies recognizing the neuronal gamma-aminobutyric acid A receptor (GABA A -R) cause severe encephalitis by triggering internalization of the antibody–receptor complexes in inhibitory synapses, which leads to hyperexcitability and dysfunction of neuronal networks. From the cerebrospinal fluid of a patient with GABA A -R encephalitis we cloned a highly expressed antibody and showed that it binds the GABA A -R and influences signal transduction in neurons, explaining clinical symptoms. Using several experimental techniques, we confirmed that the antibody cross-reacts to an oncoprotein which is known to be involved in several malignancies. We showed that cross-reactivity to this oncoprotein may also be detected in two other GABA A -R patients, suggesting that such cross-reactivity is presumably a key event in the pathogenesis of GABA A -R encephalitis.
- 22 February 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (9)
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA A receptor encephalitis
Significance: Antibodies recognizing the neuronal gamma-aminobutyric acid A receptor (GABA A -R) cause severe encephalitis by triggering internalization of the antibody–receptor complexes in inhibitory synapses, which leads to hyperexcitability and dysfunction of neuronal networks. From the cerebrospinal fluid of a patient with GABA A -R encephalitis we cloned a highly expressed antibody and showed that it binds the GABA A -R and influences signal transduction in neurons, explaining clinical symptoms. Using several experimental techniques, we confirmed that the antibody cross-reacts to an oncoprotein which is known to be involved in several malignancies. We showed that cross-reactivity to this oncoprotein may also be detected in two other GABA A -R patients, suggesting that such cross-reactivity is presumably a key event in the pathogenesis of GABA A -R encephalitis.
- Open Access
- 5 October 2020
- Published by Elsevier in Journal of Immunological Methods
- Vol. 487, 112875
Intracellular fluoride influences TASK mediated currents in human T cells
- 5 October 2020
- Published by Elsevier in Journal of Immunological Methods
- Vol. 487, 112875
Open AccessIntracellular fluoride influences TASK mediated currents in human T cells
- 17 December 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (1) , 271-276
Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release
Significance: Transendothelial trafficking of immune cells into the central nervous system (CNS) is a pathophysiological hallmark of neuroinflammatory disorders like multiple sclerosis (MS). Recent evidence suggests that the coagulation and kallikrein-kinin cascade might participate in this process. Here, we identify plasma kallikrein (KK) as a direct modulator of blood–brain barrier function in a protease-activated receptor-2–dependent manner, amplifying leukocyte trafficking into the CNS. Consequently, a deficiency of plasma prekallikrein (PK), the precursor of KK, renders mice less susceptible to experimental autoimmune encephalomyelitis (model of MS). Furthermore, PK levels were markedly enhanced in CNS lesions of MS patients. In summary, our study indicates that KK inhibition can decrease cell invasion during neuroinflammation and may offer a strategy to combat MS.
- 17 December 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (1) , 271-276
Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release
Significance: Transendothelial trafficking of immune cells into the central nervous system (CNS) is a pathophysiological hallmark of neuroinflammatory disorders like multiple sclerosis (MS). Recent evidence suggests that the coagulation and kallikrein-kinin cascade might participate in this process. Here, we identify plasma kallikrein (KK) as a direct modulator of blood–brain barrier function in a protease-activated receptor-2–dependent manner, amplifying leukocyte trafficking into the CNS. Consequently, a deficiency of plasma prekallikrein (PK), the precursor of KK, renders mice less susceptible to experimental autoimmune encephalomyelitis (model of MS). Furthermore, PK levels were markedly enhanced in CNS lesions of MS patients. In summary, our study indicates that KK inhibition can decrease cell invasion during neuroinflammation and may offer a strategy to combat MS.
- Open Access
- 8 September 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (9) , 1935
Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy—Mitochondria, Calcium Dynamics and Reactive Oxygen Species
Acquired epilepsies can arise as a consequence of brain injury and result in unprovoked seizures that emerge after a latent period of epileptogenesis. These epilepsies pose a major challenge to clinicians as they are present in the majority of patients seen in a common outpatient epilepsy clinic and are prone to pharmacoresistance, highlighting an unmet need for new treatment strategies. Metabolic and homeostatic changes are closely linked to seizures and epilepsy, although, surprisingly, no potential treatment targets to date have been translated into clinical practice. We summarize here the current knowledge about metabolic and homeostatic changes in seizures and acquired epilepsy, maintaining a particular focus on mitochondria, calcium dynamics, reactive oxygen species and key regulators of cellular metabolism such as the Nrf2 pathway. Finally, we highlight research gaps that will need to be addressed in the future which may help to translate these findings into clinical practice.
- 8 September 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (9) , 1935
Open AccessMetabolic and Homeostatic Changes in Seizures and Acquired Epilepsy—Mitochondria, Calcium Dynamics and Reactive Oxygen Species
Acquired epilepsies can arise as a consequence of brain injury and result in unprovoked seizures that emerge after a latent period of epileptogenesis. These epilepsies pose a major challenge to clinicians as they are present in the majority of patients seen in a common outpatient epilepsy clinic and are prone to pharmacoresistance, highlighting an unmet need for new treatment strategies. Metabolic and homeostatic changes are closely linked to seizures and epilepsy, although, surprisingly, no potential treatment targets to date have been translated into clinical practice. We summarize here the current knowledge about metabolic and homeostatic changes in seizures and acquired epilepsy, maintaining a particular focus on mitochondria, calcium dynamics, reactive oxygen species and key regulators of cellular metabolism such as the Nrf2 pathway. Finally, we highlight research gaps that will need to be addressed in the future which may help to translate these findings into clinical practice.
- 1 October 2014
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 275 (1-2) , 99
TRPM2 cation channel regulates detrimental immune cell invasion in ischemic stroke
- 1 October 2014
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 275 (1-2) , 99
TRPM2 cation channel regulates detrimental immune cell invasion in ischemic stroke
- Open Access
- 5 October 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 121
Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter
Neural-antigen reactive cytotoxic CD8+ T cells contribute to neuronal dysfunction and degeneration in a variety of inflammatory CNS disorders. Facing excess numbers of target cells, CNS-invading CD8+ T cells cause neuronal cell death either via confined release of cytotoxic effector molecules towards neurons, or via spillover of cytotoxic effector molecules from 'leaky’ immunological synapses and non-confined release by CD8+ T cells themselves during serial and simultaneous killing of oligodendrocytes or astrocytes.
- 5 October 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 121
Open AccessExcitotoxic neuronal cell death during an oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter
Neural-antigen reactive cytotoxic CD8+ T cells contribute to neuronal dysfunction and degeneration in a variety of inflammatory CNS disorders. Facing excess numbers of target cells, CNS-invading CD8+ T cells cause neuronal cell death either via confined release of cytotoxic effector molecules towards neurons, or via spillover of cytotoxic effector molecules from 'leaky’ immunological synapses and non-confined release by CD8+ T cells themselves during serial and simultaneous killing of oligodendrocytes or astrocytes.
- Open Access
- 11 February 2011
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 13 (1) , R21
Expression of K2P5.1 potassium channels on CD4+T lymphocytes correlates with disease activity in rheumatoid arthritis patients
CD4+ T cells express K2P5.1 (TWIK-related acid-sensitive potassium channel 2 (TASK2); KCNK5), a member of the two-pore domain potassium channel family, which has been shown to influence T cell effector functions. Recently, it was shown that K2P5.1 is upregulated upon (autoimmune) T cell stimulation. The aim of this study was to correlate expression levels of K2P5.1 on T cells from patients with rheumatoid arthritis (RA) to disease activity in these patients.
- 11 February 2011
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 13 (1) , R21
Open AccessExpression of K2P5.1 potassium channels on CD4+T lymphocytes correlates with disease activity in rheumatoid arthritis patients
CD4+ T cells express K2P5.1 (TWIK-related acid-sensitive potassium channel 2 (TASK2); KCNK5), a member of the two-pore domain potassium channel family, which has been shown to influence T cell effector functions. Recently, it was shown that K2P5.1 is upregulated upon (autoimmune) T cell stimulation. The aim of this study was to correlate expression levels of K2P5.1 on T cells from patients with rheumatoid arthritis (RA) to disease activity in these patients.
- 24 January 2008
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 87 (3) , 263-270
The two-pore domain potassium channel TASK3 functionally impacts glioma cell death
Two-pore domain K+ channels, a recently discovered family of ion channels with a unique membrane topology, have been shown to be critically involved in cell death. We here address the functional role of TASK3 (TWIK-related acid-sensitive K+ channel, KCNK9) in human glioblastoma in vitro and in vivo. Human glioma cell lines (n = 5) as well as glioma specimens (n = 5) constitutively express TASK3 mRNA and protein. The functional impact of the potassium channel on cell survival was investigated using a medium with high (25 mM) extracellular potassium over 7 days. Using flow cytometric assessment, we show that under these culture conditions 97 ± 0.76% of all glioma cells survived. Application of the TASK channel opener isoflurane (1 vol%) resulted in a 30 ± 4% reduction of cell survival in different glioma cell lines. Simultaneous application of isoflurane and the TASK channel blockers bupivacaine (20 μM) and spermine (500 μM) completely reversed this effect. Our results demonstrate the expression of TASK3 in glioma cells in vitro and in vivo and provide a direct link between the TASK3 channel function and glioma cell survival. This implies that TASK3 channels may possibly represent a novel molecular target for the treatment of this type of cancer.
- 24 January 2008
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 87 (3) , 263-270
The two-pore domain potassium channel TASK3 functionally impacts glioma cell death
Two-pore domain K+ channels, a recently discovered family of ion channels with a unique membrane topology, have been shown to be critically involved in cell death. We here address the functional role of TASK3 (TWIK-related acid-sensitive K+ channel, KCNK9) in human glioblastoma in vitro and in vivo. Human glioma cell lines (n = 5) as well as glioma specimens (n = 5) constitutively express TASK3 mRNA and protein. The functional impact of the potassium channel on cell survival was investigated using a medium with high (25 mM) extracellular potassium over 7 days. Using flow cytometric assessment, we show that under these culture conditions 97 ± 0.76% of all glioma cells survived. Application of the TASK channel opener isoflurane (1 vol%) resulted in a 30 ± 4% reduction of cell survival in different glioma cell lines. Simultaneous application of isoflurane and the TASK channel blockers bupivacaine (20 μM) and spermine (500 μM) completely reversed this effect. Our results demonstrate the expression of TASK3 in glioma cells in vitro and in vivo and provide a direct link between the TASK3 channel function and glioma cell survival. This implies that TASK3 channels may possibly represent a novel molecular target for the treatment of this type of cancer.